Proton Therapy

Tractebel and IBA To Support Proton Therapy Construction Projects

Tractebel and IBA To Support Proton Therapy Construction Projects Tractebel (ENS Corporate Member) and IBA, the world leader in particle accelerator technology, join forces to support the construction of facilities for proton therapy (PT), an advanced form of radiation therapy designed to kill cancer cells. The agreement provides that IBA will promote Tractebel’s engineering services to its prospective…

nuclear medicine cooperation

Framatome and IBA To Partner To Advance Scale-Production Of Astatine-211

Framatome and IBA To Partner To Advance Scale-Production Of Astatine-211 Framatome (ENS Corporate Member) and IBA (Ion Beam Applications S.A., EURONEXT) announced the signature of a Memorandum Of Understanding to start a strategic partnership aimed at advancing industrial-scale production of Astatine-211 (211At), an alpha-emitting radioisotope across Europe and the United States. 211At is a highly…